Reactive oxygen species in cancer, too much or too little?

Medical Hypotheses

Volumn 69, Issue 6, 2007, Pages 1293-1298

  Lu, Fuxiong ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER PREVENTION; CARCINOGENESIS; CELL DIFFERENTIATION; COLON CARCINOMA; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; LIVER CELL CARCINOMA; LIVER MITOCHONDRION; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

COLONIC NEOPLASMS; CYCLIN D1; GLUCOSEPHOSPHATE DEHYDROGENASE; HUMANS; LIPID PEROXIDATION; MITOCHONDRIA; MODELS, BIOLOGICAL; MODELS, THEORETICAL; NEOPLASMS; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 35548947587     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.03.017     Document Type: Article

References (38)

1. Otto W. On the origin of cancer cells. Science 309 (1956) 309-314
2. Schulz T.J., Thierbach R., Voigt A., Drewes G., Mietzner B., Steinberg P., et al. Induction of oxidative metabolism by mitochondrial frataxin inhibits cancer growth: Otto Warburg revisited. J Biol Chem 281 (2006) 977-981
3. Pedersen P.L. Tumor mitochondria and the bioenergetics of cancer cells. Prog Exp Tumor Res 22 (1978) 190-274
4. Poulsen H.E. Oxidative DNA modifications. Exp Toxicol Pathol 57 Suppl. 1 (2005) 161-169
5. Omenn G.S., Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Glass A., et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334 (1996) 1150-1155
6. Bize I.B., Oberley L.W., and Morris H.P. Superoxide dismutase and superoxide radical in Morris hepatomas. Cancer Res 40 (1980) 3686-3693
7. Cheeseman K.H., Emery S., Maddix S.P., Slater T.F., Burton G.W., and Ingold K.U. Studies on lipid peroxidation in normal and tumour tissues. The Yoshida rat liver tumour. Biochem J 250 (1988) 247-252
8. Van Driel B.E., and Van Noorden C.J. Oxygen insensitivity of the histochemical assay of glucose-6-phosphate dehydrogenase activity for the discrimination between nonmalignant and malignant cells. J Histochem Cytochem 47 (1999) 575-582
9. Donahue R.J., Razmara M., Hoek J.B., and Knudsen T.B. Direct influence of the p53 tumor suppressor on mitochondrial biogenesis and function. FASEB J 15 (2001) 635-644
10. Hervouet E., Demont J., Pecina P., Vojtiskova A., Houstek J., Simonnet H., et al. A new role for the von Hippel-Lindau tumor suppressor protein: stimulation of mitochondrial oxidative phosphorylation complex biogenesis. Carcinogenesis 26 (2005) 531-539
11. Xu Z., Chen L., Leung L., Yen T.S., Lee C., and Chan J.Y. Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia. Proc Natl Acad Sci USA 102 (2005) 4120-4125
12. Wang C., Li Z., Lu Y., Du R., Katiyar S., Yang J., et al. Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function. Proc Natl Acad Sci USA 103 (2006) 11567-11572
13. Savagner F., Franc B., Guyetant S., Rodien P., Reynier P., and Malthiery Y. Defective mitochondrial ATP synthesis in oxyphilic thyroid tumors. J Clin Endocrinol Metab 86 (2001) 4920-4925
14. Simonnet H., Alazard N., Pfeiffer K., Gallou C., Beroud C., Demont J., et al. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogenesis 23 (2002) 759-768
15. Yin P.H., Lee H.C., Chau G.Y., Wu Y.T., Li S.H., Lui W.Y., et al. Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma. Br J Cancer 90 (2004) 2390-2396
16. Singh K.K., Kulawiec M., Still I., Desouki M.M., Geradts J., and Matsui S. Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis. Gene 354 (2005) 140-146
17. 2 decomposition in the presence of samples from human rectal cancer. Biopolymers 74 (2004) 413-421
18. Wang Z., Zheng R., Fu S., Chen Y., Duan G., Qin D., et al. Role of superoxide anion on the proliferation and c-Ha-ras or p53 expression in prostate cancer cell line PC3. Urol Res 26 (1998) 349-353
19. Szatrowski T.P., and Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51 (1991) 794-798
20. Petros J.A., Baumann A.K., Ruiz-Pesini E., Amin M.B., Sun C.Q., Hall J., et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 102 (2005) 719-724
21. Michiels C., Raes M., Toussaint O., and Remacle J. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med 17 (1994) 235-248
22. Das U. A radical approach to cancer. Med Sci Monit 8 (2002) RA79-RA92
23. Biasi F., Tessitore L., Zanetti D., Cutrin J.C., Zingaro B., Chiarpotto E., et al. Associated changes of lipid peroxidation and transforming growth factor beta1 levels in human colon cancer during tumour progression. Gut 50 (2002) 361-367
24. Zanetti D., Poli G., Vizio B., Zingaro B., Chiarpotto E., and Biasi F. 4-hydroxynonenal and transforming growth factor-beta1 expression in colon cancer. Mol Aspects Med 24 (2003) 273-280
25. Gago-Dominguez M., Castelao J.E., Pike M.C., Sevanian A., and Haile R.W. Role of lipid peroxidation in the epidemiology and prevention of breast cancer. Cancer Epidemiol Biomar 14 (2005) 2829-2839
26. Horimoto M., Resnick M.B., Konkin T.A., Routhier J., Wands J.R., and Baffy G. Expression of uncoupling protein-2 in human colon cancer. Clin Cancer Res 10 (2004) 6203-6207
27. Barron E.T., Smyth P.P., McDermott E.W., Tobbia I.N., and Higgins N.J. Quantitative cytochemistry of glucose-6-phosphate dehydrogenase in benign and malignant breast tumours. Eur J Cancer 27 (1991) 985-989
28. Herting B., Meixensberger J., Roggendorf W., and Reichmann H. Metabolic patterns in meningiomas. J Neurooncol 65 (2003) 119-123
29. Dutu R., Nedelea M., Veluda G., and Burculet V. Cytoenzymologic investigations on carcinomas of the cervix uteri. Acta Cytol 24 (1980) 160-166
30. Kobari M., Hisano H., Matsuno S., Sato T., Kan M., and Tachibana T. Establishment of six human pancreatic cancer cell lines and their sensitivities to anti-tumor drugs. Tohoku J Exp Med 150 (1986) 231-248
31. Zerban H., Preussmann R., and Bannasch P. Quantitative morphometric comparison between the expression of two different "marker enzymes" in preneoplastic liver lesions induced in rats with low doses of N-nitrosodiethanolamine. Cancer Lett 43 (1988) 99-104
32. Ahn Y.S., Chemeris G.Y., Turusov V.S., and Bannasch P. Enzymic pattern of preneoplastic and neoplastic lesions induced in the kidney of CBA mice by 1,2-dimethylhydrazine. Toxicol Pathol 22 (1994) 415-422
33. Basso R.L., Pagani G., Silva S., Vitale A., and Vanzulli A. Glucose-6-phosphate dehydrogenase and succinate dehydrogenase in metastatic cells of Lewis lung carcinoma. Boll Soc Ital Biol Sper 59 (1983) 1183-1189
34. Bannasch P., Hacker H.J., Klimek F., and Mayer D. Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis. Adv Enzyme Regul 22 (1984) 97-121
35. Dumitru I.F., and Nechifor M.T. Decrease in yeast glucose-6-phosphate dehydrogenase activity due to oxygen free radicals. Int J Biochem 26 (1994) 229-233
36. Hospodar'ov D.V., Bailiak M.M., and Lushchak V.I. Free radical inactivation of glucose-6-phosphate dehydrogenase in Saccharomyces cerevisiae in vitro. Ukr Biokhim Zh 77 (2005) 58-64
37. Szweda L.I., and Stadtman E.R. Iron-catalyzed oxidative modification of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides. Structural and functional changes. J Biol Chem 267 (1992) 3096-3100
38. Friguet B., Szweda L.I., and Stadtman E.R. Susceptibility of glucose-6-phosphate dehydrogenase modified by 4-hydroxy-2-nonenal and metal-catalyzed oxidation to proteolysis by the multicatalytic protease. Arch Biochem Biophys 311 (1994) 168-173